Suchergebnisse - "Oluwole, Olalekan O"

PubPharm (14)

1

Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma

enthalten in: Blood advances | 2023

von Scordo, M. | Flynn, J. | Gonen, M. | +19

CommentIn: Blood Adv. 2024 Feb 13;8(3):797-798. - PMID 38191740

2

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

enthalten in: Blood advances | 2023

von Bhaskar, S. | Patel, V. | Porter, D. | +12

3

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

enthalten in: Blood advances | 2023

von Wudhikarn, K. | Tomas, A. | Flynn, J. | +12

4

Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice : Results From the US Lymphoma CAR T Consortium

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Wang, Y. | Jain, P. | Locke, F. | +26

5

Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma : phase 1 UNIVERSAL trial interim results

enthalten in: Nature medicine | 2023

von Mailankody, S. | Matous, J. | Chhabra, S. | +15

CommentIn: Nat Med. 2023 Feb;29(2):303-304. - PMID 36690813

6

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma

enthalten in: Haematologica | 2023

von Zurko, J. | Ramdial, J. | Shadman, M. | +39

7

Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma : Results from the US Lymphoma CAR-T Consortium

enthalten in: Clinical lymphoma, myeloma & leukemia | 2022

von Jacobs, M. | Jain, M. | Gao, F. | +23

8

Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas

enthalten in: Transplantation and cellular therapy | 2022

von Riedell, P. | Hwang, W. | Nastoupil, L. | +15

CommentIn: Transplant Cell Ther. 2022 Oct;28(10):621-622. - PMID 36202524

9

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia : A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research

enthalten in: Transplantation and cellular therapy | 2022

von Murthy, H. | Ahn, K. | Estrada-Merly, N. | +58

10

Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies

enthalten in: Circulation research | 2021

von Baik, A. | Oluwole, O. | Johnson, D. | +4